Cargando…
Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter
Oral squamous cell carcinoma (OSCC) has a poor prognosis and a high risk of recurrence. To improve the efficacy of OSCC therapy, it is of great significance to explore gene therapy for OSCC. The use of specific genes to regulate the targeted expression of suicide genes is a hot topic in gene therapy...
Autores principales: | Wu, Jiang, Guo, Qiong, Zhang, Guoliang, Zhao, Liying, Lv, Yvguang, Wang, Jiaqi, Liu, Jiguang, Shi, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064090/ https://www.ncbi.nlm.nih.gov/pubmed/32017381 http://dx.doi.org/10.1002/cam4.2880 |
Ejemplares similares
-
Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells
por: Wei, Xu, et al.
Publicado: (2011) -
Synergistic antitumor effects of 9.2.27-PE38KDEL and ABT-737 in primary and metastatic brain tumors
por: Yu, Xin, et al.
Publicado: (2019) -
α-MSH-PE38KDEL Kills Melanoma Cells via Modulating Erk1/2/MITF/TYR Signaling in an MC1R-Dependent Manner
por: Liu, Xilin, et al.
Publicado: (2020) -
Selective Secretion of KDEL-Bearing Proteins: Mechanisms and Functions
por: Palazzo, F. C., et al.
Publicado: (2022) -
peIF4E as an independent prognostic factor and a potential therapeutic target in diffuse infiltrating astrocytomas
por: Martínez‐Sáez, Elena, et al.
Publicado: (2016)